Article Correctness Is Author's Responsibility: Positive Results for Lemborexant in Insomnia Disorder Study

The article below may contain offensive and/or incorrect content.

SUNRISE 2 is an ongoing long-term efficacy and safety study (N=900) of adults (aged 18 to 88 years) with insomnia disorder who have difficulty falling and/or staying asleep.